Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
Clinical trial NCT04784416 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04784416
- Sponsor
- NYU Langone Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2025-10-30
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.